Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)
Japan · Delayed Price · Currency is JPY 5,588.00
-147.00 (-2.56%)
Jul 31, 2026, 3:30 PM JST
Kobayashi Pharmaceutical Market Cap
Kobayashi Pharmaceutical has a market cap or net worth of 415.41 billion as of July 31, 2026. Its market cap has increased by 5.33% in one year.
Market Cap
415.41B
Enterprise Value
351.11B
Revenue
166.80B
Ranking
n/a
PE Ratio
135.40
Stock Price
5,588.00
ChartMarket Cap Chart
Since August 17, 1999, Kobayashi Pharmaceutical's market cap has increased from 245.70B to 415.41B, an increase of 69.07%. That is a compound annual growth rate of 1.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 415.26B | 2.91% |
| Dec 30, 2025 | 403.51B | -12.87% |
| Dec 30, 2024 | 463.13B | -8.08% |
| Dec 29, 2023 | 503.84B | -22.52% |
| Dec 30, 2022 | 650.29B | -7.68% |
| Dec 30, 2021 | 704.43B | -28.53% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shiseido Company | 1.34T |
| Rohto Pharmaceutical | 561.18B |
| Lion Corporation | 484.44B |
| Paltac | 401.59B |
| KOSE Holdings | 336.67B |
| Pola Orbis Holdings | 309.57B |
| MTG Co., Ltd. | 282.58B |
| Pigeon | 246.35B |